...
首页> 外文期刊>Yonsei Medical Journal >Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast
【24h】

Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in Ductal Carcinoma in Situ and Invasive Ductal Carcinoma of the Breast

机译:MT-1 MMP,MMP2,MMP9和TIMP2 mRNA在乳腺导管原位癌和乳腺浸润性导管癌中的表达

获取原文
           

摘要

We investigated the expression of membrane type-1 (MT1)-MMP, MMP2, MMP9 and TIMP2 mRNAs and their roles in ductal carcinoma in situ (DCIS) and T1 and T2 invasive ductal carcinoma of the breast. We further compared these two types of carcinomas for differences in microvessel density, and expression of angiogenic factors and CD44std. MT1-MMP, MMP2, MMP9 and TIMP2 mRNA were expressed in both DCIS and invasive ductal carcinomas. Expression rates of MT1-MMP, MMP2, MMP9 and TIMP2 mRNAs were not statistically different between DCIS and invasive ductal carcinomas, nor did they differ statistically when grouped by tumor size, histologic grade or nuclear grade of invasive ductal carcinoma. Microvessel density and expression of VEGF and TGF-β1 were not statistically different between DCIS and invasive ductal carcinoma. CD44std expression was significantly increased in DCIS compared to invasive ductal carcinoma ( p
机译:我们调查了1型膜(MT1)-MMP,MMP2,MMP9和TIMP2 mRNA的表达及其在乳腺导管原位癌(DCIS)和T1和T2浸润性导管癌中的作用。我们进一步比较了这两种类型的癌的微血管密度,血管生成因子和CD44std的表达差异。 MT1-MMP,MMP2,MMP9和TIMP2 mRNA在DCIS和浸润性导管癌中均有表达。 DCIS与浸润性导管癌之间MT1-MMP,MMP2,MMP9和TIMP2 mRNA的表达率无统计学差异,按浸润性导管癌的肿瘤大小,组织学分级或细胞核分级分组时,它们的统计学差异也无统计学差异。 DCIS和浸润性导管癌之间的微血管密度和VEGF和TGF-β1的表达无统计学差异。与浸润性导管癌相比,DCIS中CD44std表达显着增加(p

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号